171 related articles for article (PubMed ID: 21457961)
1. Intravenous immunoglobulin and recurrent miscarriage.
Christiansen OB; Larsen EC; Husth M; Pedersen B
Fertil Steril; 2011 Jun; 95(7):e35; author reply e36. PubMed ID: 21457961
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S226-7. PubMed ID: 17055829
[No Abstract] [Full Text] [Related]
3. Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin.
Marzusch K; Dietl J; Klein R; Hornung D; Neuer A; Berg PA
Acta Obstet Gynecol Scand; 1996 Nov; 75(10):922-6. PubMed ID: 9003094
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin (IVIG) and recurrent spontaneous pregnancy loss.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2004 Sep; 82 Suppl 1():S199-200. PubMed ID: 15363726
[No Abstract] [Full Text] [Related]
5. Intravenous immune globulin for recurrent fetal loss.
Tecnologica; 1995 Nov; ():7-8. PubMed ID: 10168306
[No Abstract] [Full Text] [Related]
6. Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
Wisløff F; Crowther M
Thromb Res; 2004; 114(2):75-81. PubMed ID: 15306148
[No Abstract] [Full Text] [Related]
7. Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
Katano K; Aoki K; Ogasawara M; Aoyama T; Suzumori K
Acta Obstet Gynecol Scand; 1998 Mar; 77(3):354-6. PubMed ID: 9539288
[No Abstract] [Full Text] [Related]
8. Recurrent pregnancy loss in the context of antiphospholipid antibodies: comment on the article by Triolo et al.
Laskin CA; Clark CA; Spitzer KA
Arthritis Rheum; 2004 Mar; 50(3):1017-8. PubMed ID: 15022356
[No Abstract] [Full Text] [Related]
9. The effects of immunotherapy with intravenous immunoglobulins versus no intervention, placebo, or usual care in patients with recurrent miscarriages: a protocol for a systematic review with meta-analyses, trial sequential analyses, and individual patient data meta-analyses of randomised clinical trials.
Egerup P; Lindschou J; Gluud C; Christiansen OB
Syst Rev; 2014 Aug; 3():89. PubMed ID: 25128005
[TBL] [Abstract][Full Text] [Related]
10. Antiphospholipid antibodies and coagulation defects in women with implantation failure after IVF and recurrent miscarriage.
Stern C; Chamley L
Reprod Biomed Online; 2006 Jul; 13(1):29-37. PubMed ID: 16820106
[TBL] [Abstract][Full Text] [Related]
11. Current status of immunologic recurrent pregnancy loss.
Stern JJ; Coulam CB
Curr Opin Obstet Gynecol; 1993 Apr; 5(2):252-9. PubMed ID: 8490097
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage.
Jauniaux E; Farquharson RG; Christiansen OB; Exalto N
Hum Reprod; 2006 Sep; 21(9):2216-22. PubMed ID: 16707507
[TBL] [Abstract][Full Text] [Related]
13. Protocol for the diagnostic and therapeutic management of recurrent alloimmune abortion.
Cittadini E; Montemagno U; Pardi G; Perino A; Marcenò R; Semprini E; Cavallaro AM; Cignitti M; Cimino C; Colacurci N
Acta Eur Fertil; 1991; 22(5):267-74. PubMed ID: 1845749
[No Abstract] [Full Text] [Related]
14. Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression.
Mak A; Cheung MW; Cheak AA; Ho RC
Rheumatology (Oxford); 2010 Feb; 49(2):281-8. PubMed ID: 19965971
[TBL] [Abstract][Full Text] [Related]
15. A critical assessment of the role of antiphospholipid antibodies in infertility.
Buckingham KL; Chamley LW
J Reprod Immunol; 2009 Jun; 80(1-2):132-45. PubMed ID: 19243840
[TBL] [Abstract][Full Text] [Related]
16. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome].
Piette JC; Lê Thi Huong D; Wechsler B
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S51-4. PubMed ID: 10896991
[TBL] [Abstract][Full Text] [Related]
18. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
19. Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion.
Buyukhatipoglu H; Pehlivan Y; Onat AM
Rheumatology (Oxford); 2008 Sep; 47(9):1438-9; author reply 1439-40. PubMed ID: 18658203
[No Abstract] [Full Text] [Related]
20. Intravenous immune globulin in recurrent abortion.
Heine O; Mueller-Eckhardt G
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):39-42. PubMed ID: 8033433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
